Nephrology and Hypertension

Publications | Phd and Masters theses

Advanced search is available through Serval

Publications can be managed by accessing Serval via MyUnil


1635 publications

... | 2018 | 2017 | 2016 | 2015 | ...
 
Intensive blood pressure lowering prevents mild cognitive impairment and possible dementia and slows development of white matter lesions in brain: the SPRINT Memory and Cognition IN Decreased Hypertension (SPRINT MIND) study.
Kjeldsen S.E., Narkiewicz K., Burnier M., Oparil S., 2018/10. Blood pressure, 27 (5) pp. 247-248. Peer-reviewed.
 
Hypertension artérielle diastolique isolée : faut-il encore s’en préoccuper ? [Isolated diastolic hypertension : do we still have to care about it ?]
Berney M., Burnier M., Wuerzner G., 2018/09/12. Revue medicale suisse, 14 (618) pp. 1607-1610. Peer-reviewed.
 
Nouvelles cibles tensionnelles : beaucoup de bruit pour rien ?
Wuerzner G., Pechère-Bertschi A., Burnier M., 2018/09/12. Revue medicale suisse, 14 (618) p. 1579. Peer-reviewed.
 
Prise en charge de l’hypertension artérielle : de l’inertie thérapeutique à l’autonomie des patients [Hypertension management : from medical inertia to patient autonomy]
Burnier M., Polychronopoulou E., Wuerzner G., 2018/09/12. Revue medicale suisse, 14 (618) pp. 1602-1605. Peer-reviewed.
 
Recommandations américaines sous haute tension [American guidelines under high pressure !]
Pechère-Bertschi A., Wuerzner G., Burnier M., 2018/09/12. Revue medicale suisse, 14 (618) pp. 1594-1597. Peer-reviewed.
 
Erratum to: Multidisciplinary management of diabetic kidney disease: a systematic review and meta-analysis.
Helou N., Dwyer A., Shaha M., Zanchi A., 2018/09..
Functional magnetic resonance imaging of the kidneys: where do we stand? The perspective of the European COST Action PARENCHIMA.
Caroli A., Pruijm M., Burnier M., Selby N.M., 2018/09/01. Nephrology, dialysis, transplantation, 33 (suppl_2) pp. ii1-ii3. Peer-reviewed.
Magnetic resonance imaging biomarkers for chronic kidney disease: a position paper from the European Cooperation in Science and Technology Action PARENCHIMA.
Selby N.M., Blankestijn P.J., Boor P., Combe C., Eckardt K.U., Eikefjord E., Garcia-Fernandez N., Golay X., Gordon I., Grenier N. et al., 2018/09/01. Nephrology, dialysis, transplantation, 33 (suppl_2) pp. ii4-ii14. Peer-reviewed.
 
Nephrologie intensive : le temps de defendre nos AKI
Kissling Sebastien, Schneider Antoine G., 2018/09. Anesthésie & Réanimation, 4 (5) pp. 361-363.
Renal blood oxygenation level-dependent magnetic resonance imaging to measure renal tissue oxygenation: a statement paper and systematic review.
Pruijm M., Mendichovszky I.A., Liss P., Van der Niepen P., Textor S.C., Lerman L.O., Krediet CTP, Caroli A., Burnier M., Prasad P.V., 2018/09/01. Nephrology, dialysis, transplantation, 33 (suppl_2) pp. ii22-ii28. Peer-reviewed.
 
Take a Blood Pressure Pill or Benefit from Renal Denervation?
Kjeldsen S.E., Narkiewicz K., Burnier M., Oparil S., 2018/09/01. European heart journal, 39 (33) pp. 3010-3012. Peer-reviewed.
Antidiabétiques oraux et injectablespour le diabète de type 2 - Prise en charge multidisciplinaire du diabète : recommandations pour la pratique clinique []
Arditi C., Zanchi A., Hagon-Traub I., Burnand B., 2018/08/08. Revue medicale suisse, 14 (614) p. 1425. Peer-reviewed.
 
Bronchiectasis is highly prevalent in anti-MPO ANCA-associated vasculitis and is associated with a distinct disease presentation
Neel A., Espitia-Thibault A., Arrigoni P. P., Volteau C., Rimbert M., Masseau A., Agard C., Fakhouri F., Liberge R., Hamidou M., 2018/08. Semin Arthritis Rheum, 48 (1) pp. 70-76.
 
Clinical and genetic predictors of atypical hemolytic uremic syndrome phenotype and outcome
Schaefer F., Ardissino G., Ariceta G., Fakhouri F., Scully M., Isbel N., Lommele A., Kupelian V., Gasteyger C., Greenbaum L. A. et al., 2018/08. Kidney Int, 94 (2) pp. 408-418.
 
Renal denervation achieved by endovascular delivery of ultrasound in RADIANCE-HTN SOLO or by radiofrequency energy in SPYRAL HTN-OFF and SPYRAL-ON lowers blood pressure.
Kjeldsen S.E., Narkiewicz K., Burnier M., Oparil S., 2018/08. Blood pressure, 27 (4) pp. 185-187. Peer-reviewed.
 
Final Farewell to Alberto Zanchetti MD.
Kjeldsen S.E., Narkiewicz K., Burnier M., Oparil S., 2018/07/21. European heart journal, 39 (28) pp. 2616-2617. Peer-reviewed.
 
Anticomplement Treatment in Atypical and Typical Hemolytic Uremic Syndrome
Fakhouri F., Loirat C., 2018/07. Semin Hematol, 55 (3) pp. 150-158.
 
Circadian variation of ticagrelor-induced platelet inhibition in healthy adulty.
Fournier S., Guenat F., Fournier A., Alberio L., Bonny O., Bertaggia Calderara D., Bardy D., Lauriers N., Harbaoui B., Monney P. et al., 2018/07/01. European heart journal. Cardiovascular pharmacotherapy, 4 (3) pp. 166-171. Peer-reviewed.
 
Copeptin and insulin resistance: effect modification by age and 11 β-HSD2 activity in a population-based study.
Canivell S., Mohaupt M., Ackermann D., Pruijm M., Guessous I., Ehret G., Escher G., Pechère-Bertschi A., Vogt B., Devuyst O. et al., 2018/07. Journal of endocrinological investigation, 41 (7) pp. 799-808. Peer-reviewed.
 
Patterns of Clinical Response to Eculizumab in Patients With C3 Glomerulopathy
Le Quintrec M., Lapeyraque A. L., Lionet A., Sellier-Leclerc A. L., Delmas Y., Baudouin V., Daugas E., Decramer S., Tricot L., Cailliez M. et al., 2018/07. Am J Kidney Dis, 72 (1) pp. 84-92.
 
Redox-Dependent Bone Alkaline Phosphatase Dysfunction Drives Part of the Complex Bone Phenotype in Mice Deficient for <i>Memo1</i>.
Moor M.B., Ramakrishnan S.K., Legrand F., Dolder S., Siegrist M., Durussel F., Centeno G., Firsov D., Hynes N.E., Hofstetter W. et al., 2018/07. JBMR plus, 2 (4) pp. 195-205. Peer-reviewed.
 
Association of 24-Hour Blood Pressure With Urinary Sodium Excretion in Healthy Adults.
van der Stouwe J.G., Carmeli C., Aeschbacher S., Schoen T., Krisai P., Wenger G., Ehret G., Ponte B., Pruijm M., Ackermann D. et al., 2018/06/11. American journal of hypertension, 31 (7) pp. 784-791. Peer-reviewed.
 
Ambulatory arterial stiffness index and blood pressure response to renal denervation.
Burnier M., 2018/06. Journal of hypertension, 36 (6) pp. 1272-1275. Peer-reviewed.
Effects of the SGLT-2 Inhibitor Empagliflozin on Renal Tissue Oxygenation in Non-Diabetic Subjects: A Randomized, Double-Blind, Placebo-Controlled Study Protocol.
Muller M.E., Pruijm M., Bonny O., Burnier M., Zanchi A., 2018/06. Advances in therapy, 35 (6) pp. 875-885. Peer-reviewed.
 
In memoriam: Alberto Zanchetti.
Kjeldsen S.E., Narkiewicz K., Burnier M., Oparil S., 2018/06. Blood pressure, 27 (3) pp. 123-124. Peer-reviewed.
 
Update on Endothelin Receptor Antagonists in Hypertension.
Burnier M., 2018/05/19. Current hypertension reports, 20 (6) p. 51. Peer-reviewed.
 
Associations of Urinary Caffeine and Caffeine Metabolites With Arterial Stiffness in a Large Population-Based Study.
Ponte B., Pruijm M., Ackermann D., Ehret G., Ansermot N., Staessen J.A., Vogt B., Pechère-Bertschi A., Burnier M., Martin P.Y. et al., 2018/05. Mayo Clinic proceedings, 93 (5) pp. 586-596. Peer-reviewed.
 
May Measurement Month 2017: an analysis of blood pressure screening results worldwide.
Beaney T, Schutte AE, Tomaszewski M, Ariti C, Burrell LM, Castillo RR, Charchar FJ, Damasceno A, Kruger R, Lackland DT et al., 2018/05. The Lancet. Global health.
 
Mediterranean diet as the diet of choice for patients with chronic kidney disease.
Chauveau P., Aparicio M., Bellizzi V., Campbell K., Hong X., Johansson L., Kolko A., Molina P., Sezer S., Wanner C. et al., 2018/05/01. Nephrology, dialysis, transplantation, 33 (5) pp. 725-735. Peer-reviewed.
 
New 2017 American Heart Association and American College of Cardiology guideline for hypertension in the adults: major paradigm shifts, but will they help to fight against the hypertension disease burden?
Burnier M., Oparil S., Narkiewicz K., Kjeldsen S.E., 2018/04. Blood pressure, 27 (2) pp. 62-65. Peer-reviewed.
Reduced cortical oxygenation predicts a progressive decline of renal function in patients with chronic kidney disease.
Pruijm M., Milani B., Pivin E., Podhajska A., Vogt B., Stuber M., Burnier M., 2018/04. Kidney international, 93 (4) pp. 932-940. Peer-reviewed.
 
Hypertension Guidelines.
Burnier M., 2018/03/14. European heart journal, 39 (11) pp. 908-910. Peer-reviewed.
 
Plasma Potassium Determines NCC Abundance in Adult Kidney-Specific γENaC Knockout.
Boscardin E., Perrier R., Sergi C., Maillard M.P., Loffing J., Loffing-Cueni D., Koesters R., Rossier B.C., Hummler E., 2018/03. Journal of the American Society of Nephrology, 29 (3) pp. 977-990. Peer-reviewed.
 
Stratégies de prévention cardiovasculaire au cabinet [Strategies for cardiovascular disease prevention]
Gabus V., Wuerzner G., Saubade M., Favre L., Jacot Sadowski I., Nanchen D., 2018/02/28. Revue medicale suisse, 14 (596) pp. 488-492. Peer-reviewed.
 
Dialyse et réduction des coûts de la santé : des solutions éthiquement acceptables ? []
Burnier M., Martin P.Y., 2018/02/21. Revue medicale suisse, 14 (595) pp. 403-404. Peer-reviewed.
 
Microbiote et maladies rénales : liaison dangereuse ? [Gut microbiota and kidney diseases : dangerous liaisons?]
Ghajarzadeh-Wurzner A., Berney M., Teta D., Genton L., Pruijm M., 2018/02/21. Revue medicale suisse, 14 (595) pp. 422-425. Peer-reviewed.
 
Retour en dialyse après transplantation rénale : une étude rétrospective dans le canton de Vaud [Return to dialysis after kidney transplantation: a retrospective study in the Canton de Vaud]
Pedrazzini B., Golshayan D., Teta D., 2018/02/21. Revue medicale suisse, 14 (595) pp. 430-434. Peer-reviewed.
 
Blood pressure response to renal denervation is correlated with baseline blood pressure variability: a patient-level meta-analysis.
Persu A., Gordin D., Jacobs L., Thijs L., Bots M.L., Spiering W., Miroslawska A., Spaak J., Rosa J., de Jong M.R. et al., 2018/02. Journal of hypertension, 36 (2) pp. 221-229. Peer-reviewed.
 
Challenges in oscillometric blood pressure measurement in atrial fibrillation: looking for practical solutions.
Narkiewicz K., Kjeldsen S.E., Burnier M., Oparil S., 2018/02. Blood pressure, 27 (1) pp. 1-2. Peer-reviewed.
 
Diverging effects of enalapril or eplerenone in primary prevention against doxorubicin-induced cardiotoxicity.
Hullin R., Métrich M., Sarre A., Basquin D., Maillard M., Regamey J., Martin D., 2018/02/01. Cardiovascular research, 114 (2) pp. 272-281. Peer-reviewed.
 
Urinary Cadmium Excretion Is Associated With Increased Synthesis of Cortico- and Sex Steroids in a Population Study.
Bochud M., Jenny-Burri J., Pruijm M., Ponte B., Guessous I., Ehret G., Petrovic D., Dudler V., Haldimann M., Escher G. et al., 2018/02/01. The Journal of clinical endocrinology and metabolism, 103 (2) pp. 748-758. Peer-reviewed.
 
Use of oscillometric devices in atrial fibrillation: a comparison of three devices and invasive blood pressure measurement.
Halfon M., Wuerzner G., Marques-Vidal P., Taffe P., Vaucher J., Waeber B., Liaudet L., Ltaief Z., Popov M., Waeber G., 2018/02. Blood pressure, 27 (1) pp. 48-55. Peer-reviewed.
 
Dyspnée et hypertension artérielle []
Burnier M., 2018/01/24. Revue medicale suisse, 14 (591) pp. 201-202. Peer-reviewed.
 
Prise en charge de l’hypertension artérielle [Blood pressure management : what's new in 2017 ?]
Burnier M., Wuerzner G., 2018/01/10. Revue medicale suisse, 14 (588-589) pp. 46-48. Peer-reviewed.
Blood Pressure and Renal Responses to Orthostatic Stress Before and After Radiofrequency Renal Denervation in Patients with Resistant Hypertension.
Vuignier Y., Grouzmann E., Muller O., Vakilzadeh N., Faouzi M., Maillard M.P., Qanadli S.D., Burnier M., Wuerzner G., 2018. Frontiers in cardiovascular medicine, 5 p. 42. Peer-reviewed.
 
Eating During Hemodialysis Treatment: A Consensus Statement From the International Society of Renal Nutrition and Metabolism.
Kistler B.M., Benner D., Burrowes J.D., Campbell K.L., Fouque D., Garibotto G., Kopple J.D., Kovesdy C.P., Rhee C.M., Steiber A. et al., 2018/01. Journal of renal nutrition, 28 (1) pp. 4-12. Peer-reviewed.
Effect of Home Blood Pressure Monitoring on Patient's Awareness and Goal Attainment Under Antihypertensive Therapy: The Factors Influencing Results in Anti-HypertenSive Treatment (FIRST) Study.
Spirk D., Noll S., Burnier M., Rimoldi S., Noll G., Sudano I., 2018. Kidney & blood pressure research, 43 (3) pp. 979-986. Peer-reviewed.
Epidemiological and histological findings implicate matrix Gla protein in diastolic left ventricular dysfunction.
Wei F.F., Trenson S., Monney P., Yang W.Y., Pruijm M., Zhang Z.Y., Bouatou Y., Huang Q.F., Ponte B., Martin P.Y. et al., 2018. PloS one, 13 (3) pp. e0193967. Peer-reviewed.
 
Genome-Wide Meta-Analysis Unravels Interactions between Magnesium Homeostasis and Metabolic Phenotypes.
Corre T., Arjona F.J., Hayward C., Youhanna S., de Baaij JHF, Belge H., Nägele N., Debaix H., Blanchard M.G., Traglia M. et al., 2018/01. Journal of the American Society of Nephrology, 29 (1) pp. 335-348. Peer-reviewed.
Human Mutations in SLC2A9 (Glut9) Affect Transport Capacity for Urate.
Ruiz A., Gautschi I., Schild L., Bonny O., 2018. Frontiers in physiology, 9 p. 476. Peer-reviewed.
Is There a Threshold for Medication Adherence? Lessons Learnt From Electronic Monitoring of Drug Adherence.
Burnier M., 2018. Frontiers in pharmacology, 9 p. 1540. Peer-reviewed.
Patient-reported healthcare expectations in inflammatory bowel diseases.
Pittet V., Vaucher C., Froehlich F., Maillard M.H., Michetti P., Swiss IBD Cohort Study Group, 2018. PloS one, 13 (5) pp. e0197351. Peer-reviewed.
 
Prevalence of Hypertensive Phenotypes After Preeclampsia: A Prospective Cohort Study.
Ditisheim A., Wuerzner G., Ponte B., Vial Y., Irion O., Burnier M., Boulvain M., Pechère-Bertschi A., 2018/01. Hypertension, 71 (1) pp. 103-109. Peer-reviewed.
Renal Memo1 Differentially Regulates the Expression of Vitamin D-Dependent Distal Renal Tubular Calcium Transporters.
Moor M.B., Haenzi B., Legrand F., Koesters R., Hynes N.E., Bonny O., 2018. Frontiers in physiology, 9 p. 874. Peer-reviewed.
 
Should renal color Doppler ultrasonography be a routine test in newly diagnosed hypertensive patient?
Tsioufis C., Andrikou I., Pruijm M., Ponte B., Sarafidis P., Koureas A., Tousoulis D., Agabiti-Rosei E., Mancia G., Burnier M., 2018/01. Journal of hypertension, 36 (1) pp. 16-22. Peer-reviewed.
Symptoms and quality of life from patients undergoing hemodialysis in Switzerland
Delmas Philippe, Cohen Christine, Loiselle Marie-Chantal, Antonini Matteo, Pasquier Jerome, Burnier Michel, 2018. Clinical Nursing Studies, 6 (2) pp. 63-72.
Urinary steroid profiling in women hints at a diagnostic signature of the polycystic ovary syndrome: A pilot study considering neglected steroid metabolites.
Dhayat N.A., Marti N., Kollmann Z., Troendle A., Bally L., Escher G., Grössl M., Ackermann D., Ponte B., Pruijm M. et al., 2018. PloS one, 13 (10) pp. e0203903. Peer-reviewed.
 
Maladies vasculaires rares, mise en place d’un centre multidisciplinaire spécialisé au CHUV [Rare vascular diseases, building dedicated multidisciplinary specialized center]
Krieger C., Baud D., Bouchardy J., Christen-Zaech S., De Buys A., Deglise S., El Ezzi O., Fresa M., Hofer M., Hohl D. et al., 2017/12/06. Revue medicale suisse, 13 (586) pp. 2109-2115. Peer-reviewed.
 
[Hemolytic and uremic syndrome and related thrombotic microangiopathies: Epidemiology, pathophysiology and clinics]
Rafat C., Coppo P., Fakhouri F., Fremeaux-Bacchi V., Loirat C., Zuber J., Rondeau E., 2017/12. Rev Med Interne, 38 (12) pp. 817-824.
 
[Hemolytic and uremic syndrome and related thrombotic microangiopathies: Treatment and prognosis]
Rafat C., Coppo P., Fakhouri F., Fremeaux-Bacchi V., Loirat C., Zuber J., Rondeau E., 2017/12. Rev Med Interne, 38 (12) pp. 833-839.
 
A population-based approach to assess the heritability and distribution of renal handling of electrolytes.
Moulin F., Ponte B., Pruijm M., Ackermann D., Bouatou Y., Guessous I., Ehret G., Bonny O., Pechère-Bertschi A., Staessen J.A. et al., 2017/12. Kidney international, 92 (6) pp. 1536-1543. Peer-reviewed.
 
Optimizing hypertension management in renal transplantation: a call to action.
Halimi J.M., Persu A., Sarafidis P.A., Burnier M., Abramowicz D., Sautenet B., Oberbauer R., Mallamaci F., London G., Rossignol P. et al., 2017/12/01. Nephrology, dialysis, transplantation, 32 (12) pp. 1959-1962. Peer-reviewed.
 
Pregnancy-related acute kidney injury in high income countries: still a critical issue
Fakhouri F., Deltombe C., 2017/12. J Nephrol, 30 (6) pp. 767-771.
 
Reduction of cortical oxygenation in chronic kidney disease: evidence obtained with a new analysis method of blood oxygenation level-dependent magnetic resonance imaging.
Milani B., Ansaloni A., Sousa-Guimaraes S., Vakilzadeh N., Piskunowicz M., Vogt B., Stuber M., Burnier M., Pruijm M., 2017/12/01. Nephrology, dialysis, transplantation, 32 (12) pp. 2097-2105. Peer-reviewed.
 
Renal denervation in hypertension: is it the end or the beginning of a SPYRAL?
Burnier M., Narkiewicz K., Kjeldsen S.E., Oparil S., 2017/12. Blood pressure, 26 (6) pp. 319-320. Peer-reviewed.
Unusual presentations of functional parathyroid cysts: a case series and review of the literature.
El-Housseini Y., Hübner M., Boubaker A., Bruegger J., Matter M., Bonny O., 2017/11/29. Journal of medical case reports, 11 (1) p. 333. Peer-reviewed.
Multimodal imaging of retinal pigment epithelial detachments in patients with C3 glomerulopathy: case report and review of the literature.
Kheir V., Dirani A., Halfon M., Venetz J.P., Halabi G., Guex-Crosier Y., 2017/11/22. BMC ophthalmology, 17 (1) p. 207. Peer-reviewed.
Proceedings from the 2nd European Clinical Consensus Conference for device-based therapies for hypertension: state of the art and considerations for the future.
Mahfoud F., Schmieder R.E., Azizi M., Pathak A., Sievert H., Tsioufis C., Zeller T., Bertog S., Blankestijn P.J., Böhm M. et al., 2017/11/21. European heart journal, 38 (44) pp. 3272-3281. Peer-reviewed.
Dietary sodium induces a redistribution of the tubular metabolic workload.
Udwan K., Abed A., Roth I., Dizin E., Maillard M., Bettoni C., Loffing J., Wagner C.A., Edwards A., Feraille E., 2017/11/15. The Journal of physiology, 595 (22) pp. 6905-6922. Peer-reviewed.
 
C5 nephritic factors drive the biological phenotype of C3 glomerulopathies
Marinozzi M. C., Chauvet S., Le Quintrec M., Mignotet M., Petitprez F., Legendre C., Cailliez M., Deschenes G., Fischbach M., Karras A. et al., 2017/11. Kidney Int, 92 (5) pp. 1232-1241.
 
Drug adherence in hypertension.
Burnier M., 2017/11. Pharmacological research, 125 (Pt B) pp. 142-149. Peer-reviewed.
 
Electronic monitoring to diagnose and treat drug nonadherence.
Chiolero A., Santschi V., 2017/11. Journal of hypertension, 35 (11) pp. 2325-2326. Peer-reviewed.
 
Reply to Chalmers J. Guidelines under fire again!.
Messerli F.H., Hofstetter L., Agabiti-Rosei E., Burnier M., Elliott W.J., Franklin S.S., Grodzicki T., Kario K., Kjeldsen S.E., Kostis J.B. et al., 2017/11. Journal of hypertension, 35 (11) pp. 2327-2328. Peer-reviewed.
Comparative Long-Term Effect of Three Anti-P2Y12 Drugs after Percutaneous Angioplasty: An Observational Study Based on Electronic Drug Adherence Monitoring
Forni Ogna Valentina, Bassi Isabelle, Menetrey Isabelle, Muller Olivier, Tousset Eric, Fontana Pierre, Eeckhout Eric, Eap Chin B., Vrijens Bernard, Burnier Michel et al., 2017/10/25. Frontiers in Pharmacology, 8 pp. NA. Peer-reviewed.
 
Serum calcification propensity is associated with renal tissue oxygenation and resistive index in patients with arterial hypertension or chronic kidney disease.
Pruijm M., Lu Y., Megdiche F., Piskunowicz M., Milani B., Stuber M., Bachtler M., Vogt B., Burnier M., Pasch A., 2017/10. Journal of hypertension, 35 (10) pp. 2044-2052. Peer-reviewed.
Severe hyperkalemia is rescued by low-potassium diet in renal βENaC-deficient mice.
Boscardin E., Perrier R., Sergi C., Maillard M., Loffing J., Loffing-Cueni D., Koesters R., Rossier B.C., Hummler E., 2017/10. Pflugers Archiv, 469 (10) pp. 1387-1399. Peer-reviewed.
 
Treatment strategies for comorbid conditions lower residual risk in patients with treated hypertension: FOURIER and other randomized outcome trials.
Kjeldsen S.E., Narkiewicz K., Burnier M., Oparil S., 2017/10. Blood pressure, 26 (5) pp. 257-258. Peer-reviewed.
 
Comment initier un traitementantihypertenseur ? De l’évidenceà la personnalisation [How to start an antihypertensive treatment: from evidence to personalized choice]
Forni Ogna V., Braconnier P., Wuerzner A., Burnier M., Wuerzner G., 2017/09/13. Revue medicale suisse, 13 (574) pp. 1558-1564. Peer-reviewed.
 
Femmes médecins, anges gardiens ? []
Pechère-Bertschi A., Wuerzner G., Burnier M., 2017/09/13. Revue medicale suisse, 13 (574) pp. 1555-1556. Peer-reviewed.
 
Hypertension et dysplasie fibromusculaire :au-delà des artères rénales [Fibromuscular dysplasia and hypertension : beyond renal arteries]
Wuerzner G., Krieger C., Bouchardy J., Toubiana L., Delmotte P., Van der Niepen P., Déglise S., Qanadli S., Burnier M., Mazzolai L. et al., 2017/09/13. Revue medicale suisse, 13 (574) pp. 1580-1583. Peer-reviewed.
 
Nurse interventions to improve medication adherence among discharged older adults: a systematic review.
Verloo H., Chiolero A., Kiszio B., Kampel T., Santschi V., 2017/09/01. Age and ageing, 46 (5) pp. 747-754. Peer-reviewed.
Safety and Tolerability Study of an Intravenously Administered Small Interfering Ribonucleic Acid (siRNA) Post On-Pump Cardiothoracic Surgery in Patients at Risk of Acute Kidney Injury.
Demirjian S., Ailawadi G., Polinsky M., Bitran D., Silberman S., Shernan S.K., Burnier M., Hamilton M., Squiers E., Erlich S. et al., 2017/09. Kidney international reports, 2 (5) pp. 836-843. Peer-reviewed.
 
Seasonality of sodium and potassium consumption in Switzerland. Data from three cross-sectional, population-based studies.
Marti-Soler H., Pommier C., Bochud M., Guessous I., Ponte B., Pruijm M., Ackermann D., Forni Ogna V., Paccaud F., Burnier M. et al., 2017/09. Nutrition, metabolism, and cardiovascular diseases, 27 (9) pp. 792-798. Peer-reviewed.
 
Expertise: no longer a sine qua non for guideline authors?
Messerli F.H., Hofstetter L., Agabiti-Rosei E., Burnier M., Elliott W.J., Franklin S.S., Grodzicki T., Kario K., Kjeldsen S.E., Kostis J.B. et al., 2017/08. Journal of hypertension, 35 (8) pp. 1564-1566. Peer-reviewed.
 
Prevention of heart failure mortality and hospitalizations in SPRINT, EMPA-REG, ALLHAT and HYVET: are diuretics the clue?
Burnier M., Narkiewicz K., Kjeldsen S.E., 2017/08. Blood pressure, 26 (4) pp. 193-194. Peer-reviewed.
 
Prevention of lupus nephritis development in NZB/NZW mice by selective blockade of CD28
Laurent L., Le Fur A., Bloas R. L., Neel M., Mary C., Moreau A., Poirier N., Vanhove B., Fakhouri F., 2017/08. Eur J Immunol, 47 (8) pp. 1368-1376.
 
Renal Tubular Ubiquitin-Protein Ligase NEDD4-2 Is Required for Renal Adaptation during Long-Term Potassium Depletion.
Al-Qusairi L., Basquin D., Roy A., Rajaram R.D., Maillard M.P., Subramanya A.R., Staub O., 2017/08. Journal of the American Society of Nephrology, 28 (8) pp. 2431-2442. Peer-reviewed.
 
L’importance de la diminution de la pression artérielle nocturne
Braconnier Philippe, Forni Ogna Valentina, Wuerzner Grégoire, Burnier Michel, 2017/07/19. Info@herz+gefäss, 4 (7) pp. 24-27.
Changing trends in end-stage renal disease patients with diabetes.
Lu Y., Stamm C., Nobre D., Pruijm M., Teta D., Cherpillod A., Halabi G., Phan O., Fumeaux Z., Bullani R. et al., 2017/07/11. Swiss medical weekly, 147 pp. w14458. Peer-reviewed.
Glycaemic, blood pressure and lipid goal attainment and chronic kidney disease stage of type 2 diabetic patients treated in primary care practices.
Corcillo A., Pivin E., Lalubin F., Pitteloud N., Burnier M., Zanchi A., 2017/07/11. Swiss medical weekly, 147 pp. w14459. Peer-reviewed.
 
As we grow old: nutritional considerations for older patients on dialysis.
Johansson L., Fouque D., Bellizzi V., Chauveau P., Kolko A., Molina P., Sezer S., Ter Wee P.M., Teta D., Carrero J.J. et al., 2017/07/01. Nephrology, dialysis, transplantation, 32 (7) pp. 1127-1136. Peer-reviewed.
 
International and multidisciplinary expert recommendations for the use of biologics in systemic lupus erythematosus
Kleinmann J. F., Tubach F., Le Guern V., Mathian A., Richez C., Saadoun D., Sacre K., Sellam J., Seror R., Amoura Z. et al., 2017/06. Autoimmun Rev, 16 (6) pp. 650-657.
 
The INTERSTROKE Study: hypertension is by far the most important modifiable risk factor for stroke.
Kjeldsen S.E., Narkiewicz K., Burnier M., Oparil S., 2017/06. Blood pressure, 26 (3) pp. 131-132. Peer-reviewed.
 
Does spontaneous remission occur in polyarteritis nodosa?
.
Beyaert S., Pruijm M., Qanadli S.D., Vollenweider P., Halfon M., 2017/05. Clinical nephrology, 87 (2017) (5) pp. 255-260. Peer-reviewed.
 
Cardiovascular Efficacy and Safety of Bococizumab in High-Risk Patients.
Ridker PM, Revkin J, Amarenco P, Brunell R, Curto M, Civeira F, Flather M, Glynn RJ, Gregoire J, Jukema JW et al., 2017/04. New England Journal of Medicine.
 
Hypertension in dialysis patients : a consensus document by the European Renal and Cardiovascular Medicine (EURECA-m) working group of the European Renal Association – European Dialysis and Transplant Association (ERA-EDTA) and the Hypertension and the Kidney working group of the European Society of Hypertension (ESH)*
Sarafidis Pantelis A., Persu Alexandre, Agarwal Rajiv, Burnier Michel, de Leeuw Peter, Ferro Charles, Halimi Jean-Michel, Heine Gunnar, Jadoul Michel, Jarraya Faical et al., 2017/04. Journal of Hypertension, 35 (4) pp. 657-676. Peer-reviewed.
 
Hypertension in dialysis patients: a consensus document by the European Renal and Cardiovascular Medicine (EURECA-m) working group of the European Renal Association-European Dialysis and Transplant Association (ERA-EDTA) and the Hypertension and the Kidney working group of the European Society of Hypertension (ESH).
Sarafidis P.A., Persu A., Agarwal R., Burnier M., de Leeuw P., Ferro C.J., Halimi J.M., Heine G.H., Jadoul M., Jarraya F. et al., 2017/04/01. Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, 32 (4) pp. 620-640. Peer-reviewed.
 
Is there a place for a dual angiotensin receptor-neprilysin inhibitor in the treatment of hypertension?
Burnier M., 2017/04. Journal of hypertension, 35 (4) pp. 726-728. Peer-reviewed.
 
Performance of targeted screening for the identification of hypertension in children.
Bloetzer C., Bovet P., Paccaud F., Burnier M., Chiolero A., 2017/04. Blood pressure, 26 (2) pp. 87-93. Peer-reviewed.
 
Pharmacokinetics of Pomalidomide in a Patient Receiving Hemodialysis Using a High-Cutoff Filter.
Dao K., Chtioui H., Lu Y., Peer C.J., Figg W.D., Pruijm M., Buclin T., Kissling S., 2017/04. American journal of kidney diseases, 69 (4) pp. 553-554. Peer-reviewed.
Renal Fanconi Syndrome and Hypophosphatemic Rickets in the Absence of Xenotropic and Polytropic Retroviral Receptor in the Nephron.
Ansermet C., Moor M.B., Centeno G., Auberson M., Hu D.Z., Baron R., Nikolaeva S., Haenzi B., Katanaeva N., Gautschi I. et al., 2017/04. Journal of the American Society of Nephrology : JASN, 28 (4) pp. 1073-1078. Peer-reviewed.
 
The INTERSALT Study and the complex relationship between salt intake and blood pressure.
Kjeldsen S.E., Narkiewicz K., Burnier M., Oparil S., 2017/04. Blood pressure, 26 (2) pp. 65-66. Peer-reviewed.
Associations of sodium, potassium and protein intake with blood pressure and hypertension in Switzerland.
Glatz N., Chappuis A., Conen D., Erne P., Péchère-Bertschi A., Guessous I., Forni V., Gabutti L., Muggli F., Gallino A. et al., 2017/03/21. Swiss medical weekly, 147 pp. w14411.
Erratum to: A new prescription model for regional citrate anticoagulation in therapeutic plasma exchanges.
Kissling S., Legallais C., Pruijm M., Teta D., Vogt B., Burnier M., Rondeau E., Ridel C., 2017/03/09. BMC nephrology, 18 (1) p. 84. Peer-reviewed.
A new prescription model for regional citrate anticoagulation in therapeutic plasma exchanges.
Kissling S., Legallais C., Pruijm M., Teta D., Vogt B., Burnier M., Rondeau E., Ridel C., 2017/03/01. BMC nephrology, 18 (1) p. 81. Peer-reviewed.
 
Atypical hemolytic uremic syndrome and C3 glomerulopathy: conclusions from a "Kidney Disease: Improving Global Outcomes" (KDIGO) Controversies Conference
Goodship T. H., Cook H. T., Fakhouri F., Fervenza F. C., Fremeaux-Bacchi V., Kavanagh D., Nester C. M., Noris M., Pickering M. C., Rodriguez de Cordoba S. et al., 2017/03. Kidney Int, 91 (3) pp. 539-551.
 
Atteintes extrarénales de la polykystose rénale: signes cliniques,dépistage et prise en charge [Extra-renal manifestations of the autosomal dominant polycystic kidney disease]
Butscher A., Phan O., Bonny O., 2017/02/22. Revue medicale suisse, 13 (551) pp. 450-456. Peer-reviewed.
 
Avancées thérapeutiques dans les maladies rénales associéesaux gammapathies monoclonales [Therapeutic advances in monoclonal gammopathy-associated renal diseases]
Boesch A., Burnier M., Cairoli A., Kissling S., 2017/02/22. Revue medicale suisse, 13 (551) pp. 462-467. Peer-reviewed.
 
Dialyse à domicile : retour vers le futur
Burnier M., Martin P.Y., 2017/02/22. Revue medicale suisse, 13 (551) pp. 443-444. Peer-reviewed.
 
Inégalité homme-femme face aux maladies rénales chroniques : mythe ou réalité ? [Gender differences in chronic kidney diseases : myth or reality ?]
Mehier P., Burnier M., Pruijm M., 2017/02/22. Revue medicale suisse, 13 (551) pp. 473-476. Peer-reviewed.
 
The Global Burden of Disease Study 2015 and Blood Pressure.
Kjeldsen S.E., Narkiewicz K., Burnier M., Oparil S., 2017/02. Blood pressure, 26 (1) p. 1. Peer-reviewed.
 
The Swiss Kidney Stone Cohort: An Observational Study to Unravel the Cause of Renal Stone Formation.
Roth B., Bonny O., Swiss Kidney Stone Cohort Investigators, 2017/02. European urology focus, 3 (1) pp. 7-9. Peer-reviewed.
 
Échanges plasmatiques en néphrologie : techniques et indications [Plasma exchange in nephrology: Indications and technique]
Ridel C., Kissling S., Mesnard L., Hertig A., Rondeau É., 2017/02. Nephrologie & therapeutique, 13 (1) pp. 43-55. Peer-reviewed.
Team-based care for improving hypertension management among outpatients (TBC-HTA): study protocol for a pragmatic randomized controlled trial.
Santschi V., Wuerzner G., Chiolero A., Burnand B., Schaller P., Cloutier L., Paradis G., Burnier M., 2017/01/21. BMC cardiovascular disorders, 17 (1) p. 39. Peer-reviewed.
 
Hypertension : quoi de neuf ? [Hypertension]
Burnier M., Wuerzner G., 2017/01/11. Revue medicale suisse, 13 (544-545) pp. 61-65. Peer-reviewed.
Antagonist Anti-CD28 Therapeutics for the Treatment of Autoimmune Disorders
Vanhove B., Poirier N., Fakhouri F., Laurent L., t Hart B., Papotto P. H., Rizzo L. V., Zaitsu M., Issa F., Wood K. et al., 2017. Antibodies (Basel), 6 (4).
Current Situation of Medication Adherence in Hypertension.
Vrijens B., Antoniou S., Burnier M., de la Sierra A., Volpe M., 2017. Frontiers in pharmacology, 8 p. 100. Peer-reviewed.
 
Diabète de type 2 et néphropathie
Zanchi Anne, 2017/01. La Gazette Médicale info@gériatrie pp. 22-24.
 
Hemolytic Uremic Syndrome in Pregnancy and Postpartum
Bruel A., Kavanagh D., Noris M., Delmas Y., Wong E. K. S., Bresin E., Provot F., Brocklebank V., Mele C., Remuzzi G. et al., 2017. Clin J Am Soc Nephrol, 12 (8) pp. 1237-1247.
 
Insuffisance rénale et diabète: les précautions à prendre.
Zanchi Anne, Cherpillod Anne, Pitteloud Nelly, Burnier Michel, Pruijm Menno, 2017. Forum Médical Suisse, 14 (6) pp. 100-104. Peer-reviewed.
Nephropathy in Pparg-null mice highlights PPARγ systemic activities in metabolism and in the immune system.
Toffoli B., Gilardi F., Winkler C., Soderberg M., Kowalczuk L., Arsenijevic Y., Bamberg K., Bonny O., Desvergne B., 2017. PLoS One, 12 (2) pp. e0171474. Peer-reviewed.
 
Pathogenic Variants in Complement Genes and Risk of Atypical Hemolytic Uremic Syndrome Relapse after Eculizumab Discontinuation
Fakhouri F., Fila M., Provot F., Delmas Y., Barbet C., Chatelet V., Rafat C., Cailliez M., Hogan J., Servais A. et al., 2017. Clin J Am Soc Nephrol, 12 (1) pp. 50-59.
 
Pharmacokinetics of lenalidomide during high cut-off dialysis in a patient with multiple myeloma and renal failure.
Dao K., Lu Y., Peer C.J., Figg W.D., Stadelmann R., Burnier M., Buclin T., Kissling S., 2017/01. Cancer chemotherapy and pharmacology, 79 (1) pp. 215-218. Peer-reviewed.
Relevance of positive cardiovascular outcome trial results in clinical practice: perspectives from the Academy for Cardiovascular Risk, Outcomes and Safety Studies in Type 2 Diabetes (ACROSS T2D).
Schernthaner G., Khunti K., Lotan C., Burnier M., Drexel H., Prázný M., 2017. Therapeutics and clinical risk management, 13 pp. 1569-1576. Peer-reviewed.
 
The Associations of Blood Kidney Injury Molecule-1 and Neutrophil Gelatinase-Associated Lipocalin with Progression from CKD to ESRD.
Alderson H.V., Ritchie J.P., Pagano S., Middleton R.J., Pruijm M., Vuilleumier N., Kalra P.A., 2016/12/07. Clinical journal of the American Society of Nephrology, 11 (12) pp. 2141-2149. Peer-reviewed.
 
Effect of long-term adherence to clopidogrel on the VASP-PRI after elective coronary stent implantation: a randomized controlled study.
Forni Ogna V., Menetrey I., Muller O., Tousset E., Guihard L., Fontana P., Eeckhout E., Eap C.B., Vrijens B., Burnier M. et al., 2016/12. British Journal of Clinical Pharmacology, 82 (6) pp. 1486-1497. Peer-reviewed.
 
Resistant Hypertension: Is the Number of Drugs a Reliable Marker of Resistance?
Burnier M., 2016/12. Hypertension, 68 (6) pp. 1346-1348. Peer-reviewed.
 
Treatment of high blood pressure in elderly and octogenarians: European Society of Hypertension statement on blood pressure targets.
Kjeldsen S.E., Stenehjem A., Os I., Van de Borne P., Burnier M., Narkiewicz K., Redon J., Agabiti Rosei E., Mancia G., 2016/12. Blood pressure, 25 (6) pp. 333-336. Peer-reviewed.
 
E-learning en médecine interne : testez vos connaissances
Galland-Decker C., Schläpfer J., Wuerzner G., Monti M., 2016/11/23. Revue medicale suisse, 12 (540) pp. 2008-2013. Peer-reviewed.
 
Renal tissue oxygenation in children with chronic kidney disease due to vesicoureteral reflux.
Chehade H., Milani B., Ansaloni A., Anex C., Bassi I., Piskunowicz M., Stuber M., Cachat F., Burnier M., Pruijm M., 2016/11. Pediatric nephrology, 31 (11) pp. 2103-2111. Peer-reviewed.
Mutations in the polyglutamylase gene TTLL5, expressed in photoreceptor cells and spermatozoa, are associated with cone-rod degeneration and reduced male fertility.
Bedoni N., Haer-Wigman L., Vaclavik V., Tran V.H., Farinelli P., Balzano S., Royer-Bertrand B., El-Asrag M.E., Bonny O., Ikonomidis C. et al., 2016/10/15. Human molecular genetics, 25 (20) pp. 4546-4555. Peer-reviewed.
Nephron-Specific Deletion of Circadian Clock Gene Bmal1 Alters the Plasma and Renal Metabolome and Impairs Drug Disposition.
Nikolaeva S., Ansermet C., Centeno G., Pradervand S., Bize V., Mordasini D., Henry H., Koesters R., Maillard M., Bonny O. et al., 2016/10. Journal of the American Society of Nephrology : JASN, 27 (10) pp. 2997-3004. Peer-reviewed.
The genetics of blood pressure regulation and its target organs from association studies in 342,415 individuals.
Ehret G.B., Ferreira T., Chasman D.I., Jackson A.U., Schmidt E.M., Johnson T., Thorleifsson G., Luan J., Donnelly L.A., Kanoni S. et al., 2016/10. Nature genetics, 48 (10) pp. 1171-1184. Peer-reviewed.
 
La pollution a-t-elle un impact sur la pression artérielle ? [Does pollution have an impact on blood pressure ?]
Megdiche F., Pivin E., Wuerzner G., Burnier M., 2016/09/14. Revue medicale suisse, 12 (530) pp. 1507-1512. Peer-reviewed.
 
La recherche d’une hypertension nocturne est-elle utile ? [Usefulness of night-time blood pressure measurement]
Pivin E., Megdiche F., Burnier M., Wuerzner G., 2016/09/14. Revue medicale suisse, 12 (530) pp. 1513-1517. Peer-reviewed.
 
Médecine personnalisée et hypertension artérielle : effet de mode ou vrai défi ? []
Burnier M., Pechère-Bertschi A., Wuerzner G., 2016/09/14. Revue medicale suisse, 12 (530) pp. 1499-1500. Peer-reviewed.
 
Potassium et pression artérielle, une vieille histoire revisitée [Potassium and blood pressure, an old story, revisited]
Zisimopoulou S., Pechère-Bertschi A., Burnier M., 2016/09/14. Revue medicale suisse, 12 (530) pp. 1502-1506. Peer-reviewed.
 
Pression artérielle et glaucome : attention à la pression artérielle nocturne [Arterial hypertension and glaucoma: watch out for nocturnal blood pressure]
Martin-Du Pan R., Pruijm M., Burnier M., Sunaric-Megevand G., 2016/09/14. Revue medicale suisse, 12 (530) pp. 1518-1521. Peer-reviewed.
 
[OP.2A.02] Uromodulin Modulates The Effect Of Salt On Blood Pressure In The General Population.
Ponte B., Pruijm M., Guessous I., Ackermann D., Ehret G., Mohaupt M., Paccaud F., Vogt B., Martin P.Y., Pechere-Berstschi A. et al., 2016/09., 26th Meeting of the European Society of Hypertension (ESH), Paris, June 10-13, 2016 pp. e15 dans Journal of Hypertension. Peer-reviewed, Ovid Technologies (Wolters Kluwer Health).
Renal tubular SGK1 deficiency causes impaired K+ excretion via loss of regulation of NEDD4-2/WNK1 and ENaC.
Al-Qusairi L., Basquin D., Roy A., Stifanelli M., Rajaram R.D., Debonneville A., Nita I., Maillard M., Loffing J., Subramanya A.R. et al., 2016/08/01. American journal of physiology. Renal physiology, 311 (2) pp. F330-42. Peer-reviewed.
The impact of a multidisciplinary self-care management program on quality of life, self-care, adherence to anti-hypertensive therapy, glycemic control, and renal function in diabetic kidney disease: A Cross-over Study Protocol.
Helou N., Talhouedec D., Shaha M., Zanchi A., 2016/07/19. BMC nephrology, 17 (1) p. 88. Peer-reviewed.
 
Multidisciplinary management of diabetic kidney disease: a systematic review and meta-analysis.
Helou N., Dwyer A., Shaha M., Zanchi A., 2016/07. JBI database of systematic reviews and implementation reports, 14 (7) pp. 169-207. Peer-reviewed.
 
Terminal Complement Inhibitor Eculizumab in Adult Patients With Atypical Hemolytic Uremic Syndrome: A Single-Arm, Open-Label Trial
Fakhouri F., Hourmant M., Campistol J. M., Cataland S. R., Espinosa M., Gaber A. O., Menne J., Minetti E. E., Provot F., Rondeau E. et al., 2016/07. Am J Kidney Dis, 68 (1) pp. 84-93.
 
[OP.7D.07] INFLUENCE OF RENAL SYMPATHETIC DENERVATION ON BLOOD PRESSURE VARIABILITY: EXPERIENCE AT 11 EUROPEAN EXPERT CENTERS.
Persu A., Gordin D., Jacobs L., Thijs L., Bots M.L., Miroslawska A., Spaak J., Rosa J., De Jong M., Berra E. et al., 2016/06/01. Journal of Hypertension, 34 Suppl 2 - ESH 2016 Abstract Book pp. e96. Peer-reviewed.
 
[Retroperitoneal fibrosis in adults: Main characteristics and relevance of the diagnostic procedures based on a retrospective multicenter study on 77 cases]
Lioger B., Yahiaoui Y., Kahn J. E., Fakhouri F., Belenfant X., Papo T., Magnant J., Maillot F., Vordos D., Godeau B. et al., 2016/06. Rev Med Interne, 37 (6) pp. 387-93.
Adult nephron-specific MR-deficient mice develop a severe renal PHA-1 phenotype.
Canonica J., Sergi C., Maillard M., Klusonova P., Odermatt A., Koesters R., Loffing-Cueni D., Loffing J., Rossier B., Frateschi S. et al., 2016/05. Pflugers Archiv : European journal of physiology, 468 (5) pp. 895-908. Peer-reviewed.
Sociodemographic, behavioral and genetic determinants of allostatic load in a Swiss population-based study.
Petrovic D., Pivin E., Ponte B., Dhayat N., Pruijm M., Ehret G., Ackermann D., Guessous I., Younes S.E., Pechère-Bertschi A. et al., 2016/05. Psychoneuroendocrinology, 67 pp. 76-85. Peer-reviewed.
 
[Clinical approach to primary membranoproliferative glomerulonephritis]
Fakhouri F., 2016/04. Nephrol Ther, 12 Suppl 1 pp. S65-9.
 
Association between obesity and glomerular hyperfiltration: the confounding effect of smoking and sodium and protein intakes.
Ogna A., Forni Ogna V., Bochud M., Guessous I., Paccaud F., Burnier M., Wuerzner G., 2016/04. European journal of nutrition, 55 (3) pp. 1089-1097. Peer-reviewed.
 
Pregnancy-related thrombotic microangiopathies: Clues from complement biology
Fakhouri F., 2016/04. Transfus Apher Sci, 54 (2) pp. 199-202.
 
La prise en charge de l'insuffisance rénale doit devenir une priorité humanitaire [Chronic kidney insufficiency management must become a humanitarian priority]
Martin P.Y., Burnier M., 2016/02/24. Revue medicale suisse, 12 (507) pp. 379-380.
 
Mesures préventives de l'insuffisance rénale aiguë [Preventive measures of acute renal failure]
Schwotzer N., Burnier M., Kissling S., 2016/02/24. Revue medicale suisse, 12 (507) pp. 393-397. Peer-reviewed.
 
Quand appeler le néphrologue aux urgences? [When should the nephrologist be called in the emergency room?]
Favre N., Burnier M., Kissling S., 2016/02/24. Revue medicale suisse, 12 (507) pp. 398-403. Peer-reviewed.
 
Comparative study of the efficacy of olmesartan/amlodipine vs. perindopril/amlodipine in peripheral blood pressure after missed dose in type 2 diabetes.
Redon J., Pichler G., Missed Dose Study Group, 2016/02. Journal of hypertension, 34 (2) pp. 359-367.
 
Hypertension artérielle [News in blood pressure in 2015]
Megdiche F., Pivin E., Wuerzner G., Burnier M., 2016/01/13. Revue medicale suisse, 12 (500) pp. 44-48.
 
[OP.8E.08] Regional variations in the associations of dietary patterns with blood pressure and hypertension in Switzerland
Burnier M., Chappuis A., Glatz N., Bochud M., Swiss Salt Survey Group, 2016. pp. e110 dans Journal of Hypertension.
A novel LAMB2 gene mutation associated with a severe phenotype in a neonate with Pierson syndrome.
Zemrani B., Cachat F., Bonny O., Giannoni E., Durig J., Fellmann F., Chehade H., 2016. European Journal of Medical Research, 21 p. 19. Peer-reviewed.
 
Adherence to Medications in Uncontrolled Hypertension
Michel Burnier, Gregoire Wuerzner, 2016..
 
An international consensus approach to the management of atypical hemolytic uremic syndrome in children
Loirat C., Fakhouri F., Ariceta G., Besbas N., Bitzan M., Bjerre A., Coppo R., Emma F., Johnson S., Karpman D. et al., 2016/01. Pediatr Nephrol, 31 (1) pp. 15-39.
 
Associations of Urinary Uromodulin with Clinical Characteristics and Markers of Tubular Function in the General Population.
Pruijm M., Ponte B., Ackermann D., Paccaud F., Guessous I., Ehret G., Pechère-Bertschi A., Vogt B., Mohaupt M.G., Martin P.Y. et al., 2016. Clinical Journal of the American Society of Nephrology, 11 (1) pp. 70-80. Peer-reviewed.
 
Blockade of the Renin-Angiotensin System and the Risk of Acute Kidney Injury.
Burnier M., 2016. Journal of Clinical Hypertension, 18 (6) pp. 512-513. Peer-reviewed.
Blood Oxygenation Level-Dependent MRI to Assess Renal Oxygenation in Renal Diseases: Progresses and Challenges.
Pruijm M., Milani B., Burnier M., 2016. Frontiers in physiology, 7 p. 667. Peer-reviewed.
Chronic kidney disease in type 2 diabetic patients followed-up by primary care physicians in Switzerland: prevalence and prescription of antidiabetic drugs.
Lamine F., Lalubin F., Pitteloud N., Burnier M., Zanchi A., 2016. Swiss Medical Weekly, 146 pp. w14282. Peer-reviewed.
 
Continuation of the ESH-CHL-SHOT trial after publication of the SPRINT: rationale for further study on blood pressure targets of antihypertensive treatment after stroke.
Zanchetti A., Liu L., Mancia G., Parati G., Grassi G., Stramba-Badiale M., Silani V., Bilo G., Corrao G., Zambon A. et al., 2016. Journal of Hypertension, 34 (3) pp. 393-396. Peer-reviewed.
 
CYP17A1 Enzyme activity is linked to ambulatory blood pressure in a family-based population study.
Ackermann D., Pruijm M., Ponte B., Guessous I., Ehret G., Escher G., Dick B., Al-Alwan H., Vuistiner P., Paccaud F. et al., 2016. American Journal of Hypertension, 29 (4) pp. 484-493. Peer-reviewed.
 
European society of hypertension scientific newsletter: Update on hypertension management 2011;12:Nr. 7R: Patient adherence and pharmacological treatment of arterial hypertension,Adhärenz bei pharmakologischer Behandlung der arteriellen Hypertonie
Pruijm Menno, 2016. Journal fur Hypertonie.
 
FGF23 markers of mineral metabolism in subjects with preserved renal function
Dhayat Nasser, Ackermann Daniel, Pruijm Menno, Ponte Belen, Ehret Georg, Guessous Idris, Leichtle Alexander Benedikt, Paccaud Fred, Mohaupt Markus, Fiedler Georg-Martin et al., 2016., 53rd ERA-EDTA Congress, May 21st-24th, 2016, Vienna, Austria p. 1459 dans Nephrology Dialysis Transplantation. Peer-reviewed.
 
Fibroblast growth factor 23 and markers of mineral metabolism in individuals with preserved renal function.
Dhayat N.A., Ackermann D., Pruijm M., Ponte B., Ehret G., Guessous I., Leichtle A.B., Paccaud F., Mohaupt M., Fiedler G.M. et al., 2016. Kidney International, 90 (3) pp. 648-657. Peer-reviewed.
Genetic associations at 53 loci highlight cell types and biological pathways relevant for kidney function.
Pattaro C., Teumer A., Gorski M., Chu A.Y., Li M., Mijatovic V., Garnaas M., Tin A., Sorice R., Li Y. et al., 2016. Nature Communications, 7 p. 10023. Peer-reviewed.
 
Genome-wide Association Studies Identify Genetic Loci Associated With Albuminuria in Diabetes.
Teumer A., Tin A., Sorice R., Gorski M., Yeo N.C., Chu A.Y., Li M., Li Y., Mijatovic V., Ko Y.A. et al., 2016. Diabetes, 65 (3) pp. 803-817. Peer-reviewed.
 
Improving treatment satisfaction to increase adherence.
Chiolero A., Burnier M., Santschi V., 2016. Journal of Human Hypertension, 30 (5) pp. 295-296. Peer-reviewed.
Increasing Incidence of Obstructive Sleep Apnea and Chronic Kidney Disease: Is there a Causal Relationship?
Ogna Adam, Forni Ogna Valentina, 2016. Journal of Sleep Disorders & Therapy, 5 (3) p. 245. Peer-reviewed.
 
Les maladies rénales chroniques ne sont pas toutes silencieuses [Chronic kidney diseases do not always pass unnoticed].
Alves C., Pruijma M., Rotman S., Bonny O., 2016. Revue Médicale Suisse, 12 (507) pp. 382-386. Peer-reviewed.
 
OS 03-06 EFFECT OF LONG-TERM ENRICHED POTASSIUM SALT CONSUMPTION ON ALL CAUSES MORTALITY IN CHINESE LIVING IN NURSING HOUSES-A PRELIMINARY ANALYSIS.
Zhang H., Wang Q., Guo Y., Li D., Zhang B., Dong Y., Huang X., Liu Y., Zhao J., Li W. et al., 2016. Journal of Hypertension, 34 Suppl 1 - ISH 2016 Abstract Book pp. e52-e53. Peer-reviewed.
 
Physiologic Control of the Circadian Variability in Blood Pressure
Burnier Michel, Bonny Olivier, Wuerzner Gregoire, 2016. pp. 149-163 dans Blood Pressure Monitoring in Cardiovascular Medicine and Therapeutics, Springer.
Premature Destruction of Microbubbles during Voiding Urosonography in Children and Possible Underlying Mechanisms: Post Hoc Analysis from the Prospective Study.
Piskunowicz M., Swieton D., Rybczynska D., Szarmach A., Szurowska E., Pruijm M., 2016. BioMed research international, 2016 p. 1764692. Peer-reviewed.
Prevalence and determinants of chronic kidney disease in the Swiss population.
Forni Ogna V., Ogna A., Ponte B., Gabutti L., Binet I., Conen D., Erne P., Gallino A., Guessous I., Hayoz D. et al., 2016. Swiss Medical Weekly, 146 pp. w14313. Peer-reviewed.
Relation of 24-hour urinary caffeine and caffeine metabolite excretions with self-reported consumption of coffee and other caffeinated beverages in the general population.
Petrovic D., Estoppey Younes S., Pruijm M., Ponte B., Ackermann D., Ehret G., Ansermot N., Mohaupt M., Paccaud F., Vogt B. et al., 2016. Nutrition & metabolism, 13 p. 81. Peer-reviewed.
Safety and immunogenicity of a chimpanzee adenovirus-vectored Ebola vaccine in healthy adults: a randomised, double-blind, placebo-controlled, dose-finding, phase 1/2a study.
De Santis O., Audran R., Pothin E., Warpelin-Decrausaz L., Vallotton L., Wuerzner G., Cochet C., Estoppey D., Steiner-Monard V., Lonchampt S. et al., 2016. Lancet. Infectious Diseases, 16 (3) pp. 311-320. Peer-reviewed.
 
Sleep Characteristics in Early Stages of Chronic Kidney Disease in the HypnoLaus Cohort.
Ogna A., Forni Ogna V., Haba Rubio J., Tobback N., Andries D., Preisig M., Tafti M., Vollenweider P., Waeber G., Marques-Vidal P. et al., 2016. Sleep, 39 (4) pp. 945-953. Peer-reviewed.
 
Translational implications of endothelial cell dysfunction in association with chronic allograft rejection
Bruneau S., Wedel J., Fakhouri F., Nakayama H., Boneschansker L., Irimia D., Daly K. P., Briscoe D. M., 2016/01. Pediatr Nephrol, 31 (1) pp. 41-51.
 
A new technique with high reproducibility to estimate renal oxygenation using BOLD-MRI in chronic kidney disease.
Piskunowicz M., Hofmann L., Zuercher E., Bassi I., Milani B., Stuber M., Narkiewicz K., Vogt B., Burnier M., Pruijm M., 2015/12. Magnetic Resonance Imaging, 33 (3) pp. 253-261. Peer-reviewed.
 
Drug adherence monitoring in clinical trials: a necessity for a correct assessment of the efficacy and safety of antihypertensive therapies.
Burnier M., Wuerzner G., 2015/12. Journal of Hypertension, 33 (12) pp. 2395-2398. Peer-reviewed.
Furosemide stimulation of parathormone in humans: role of the calcium-sensing receptor and the renin-angiotensin system.
Muller M.E., Forni Ogna V., Maillard M., Stoudmann C., Zweiacker C., Anex C., Wuerzner G., Burnier M., Bonny O., 2015/12. Pflugers Archiv, 467 (12) pp. 2413-2421. Peer-reviewed.
New anthropometry-based age- and sex-specific reference values for urinary 24-hour creatinine excretion based on the adult Swiss population (epublish)
Forni Ogna V., Ogna A., Vuistiner P., Pruijm M., Ponte B., Ackermann D., Gabutti L., Vakilzadeh N., Mohaupt M., Martin P.Y. et al., 2015/12. Bmc Medicine, 13 (1) p. 40. Peer-reviewed.
 
Pharmacokinetic modelling of dialytic clearance in a case of acyclovir intoxication.
Kissling S., Fuchs A., Gobin N., Vogt B., Burnier M., Decosterd L.A., Buclin T., Livio F., 2015/11. International Journal of Antimicrobial Agents, 45 (3) pp. 325-327. Peer-reviewed.
 
Heritability of ambulatory and office blood pressure in the Swiss population.
Alwan H., Ehret G., Ponte B., Pruijm M., Ackermann D., Guessous I., Staessen J.A., Asayama K., Kutalik Z., Vuistiner P. et al., 2015/10. Journal of Hypertension, 33 (10) pp. 2061-2067. Peer-reviewed.
Clinical determinants of adrenal vein sampling success
Berney M., Matter M., Pechère-Bertschi A., Burnier M., Wuerzner G., 2015/09/23. Cardiovascular Medicine, 18 (09) pp. 246-251. Peer-reviewed.
 
Faut-il adapter le traitement des patients hypertendus lorsqu'ils sont exposés è de hautes altitudes? [Should hypertensive patients adapt their antihypertensive drugs during high altitude exposure?]
Wuerzner G., Allemann Y., 2015/09/09. Revue medicale suisse, 11 (485) pp. 1645-1647. Peer-reviewed.
 
L'hypertension artériele à lère de l'environnement et d'internet [Arterial hypertension in the era of environmental concern and the internet]
Wuerzner G., 2015/09/09. Revue medicale suisse, 11 (485) pp. 1635-1636. Peer-reviewed.
 
Le travail de nuit ou en rotation : quel impact sur la pression artérielle? [Shift work and night work: what effect on blood pressure?]
Cassat M., Wuerzner G., Burnier M., 2015/09/09. Revue medicale suisse, 11 (485) pp. 1648-1654. Peer-reviewed.
 
Serum 25-hydroxyvitamin D level and kidney function decline in a Swiss general adult population.
Guessous I., McClellan W., Kleinbaum D., Vaccarino V., Hugues H., Boulat O., Marques-Vidal P., Paccaud F., Theler J.M., Gaspoz J.M. et al., 2015/07/07. Clinical journal of the American Society of Nephrology, 10 (7) pp. 1162-1169. Peer-reviewed.
 
Intermittent hemodialysis treatment in cefepime-induced neurotoxicity: Case report, pharmacokinetic modeling, and review of the literature.
Mani L.Y., Kissling S., Viceic D., Vogt B., Burnier M., Buclin T., Renard D., 2015/07. Hemodialysis International. International Symposium On Home Hemodialysis, 19 (2) pp. 333-343. Peer-reviewed.
 
Urinary angiotensinogen and salt sensitivity of blood pressure: the challenge of finding biomarkers of salt-sensitivity.
Burnier M., 2015/07. Journal of Hypertension, 33 (7) pp. 1368-1370.
 
1D.03: Inactive matrix GLA protein is associated with renal resistive index in a population-based study
Pivin E., Pruijm M., Ackermann D., Guessous I., Ehret G., Pechère-Bertschi A., Paccaud F., Mohaupt M., Vermeer C., Staessen J.A. et al., 2015/06., ESH 2015: 25th European meeting on hypertension and cardiovascular protection, 12-15 June 2015, Milan (Italy) pp. e15 dans J Hypertension. Peer-reviewed.
 
4B.05: Plasma Lasma copeptin is associated with insulin resistance in a Swiss population-based study
Canivell S., Ponte B., Pruijm M., Ackermann D., Guessous I., Ehret G., Paccaud F., Pechere-Bertschi A., Mohaupt M., Vogt B. et al., 2015/06., ESH 2015: 25th European meeting on hypertension and cardiovascular protection, 12-15 June 2015, Milan (Italy) pp. e54 dans J Hypertension. Peer-reviewed.
 
5C.09: Heritability of renal function parameters and electrolyte levels in the Swiss population
Moulin F., Ponte B., Pruijm M., Ackermann D., Guessous I., Ehret G., Bonny O., Pechere-Bertschi A., Staessen J.A., Paccaud F. et al., 2015/06., ESH 2015: 25th European meeting on hypertension and cardiovascular protection, 12-15 June 2015, Milan (Italy) pp. e70 dans J Hypertension. Peer-reviewed.
 
9C.09: TREATMENT WITH CANDESARTAN UNMASKS HIGHER URINARY NOREPINEPHRINE EXCRETION IN WHITE COAT HYPERTENSIVE PATIENTS COMPARED TO HEALTHY NORMOTENSIVE PARTICIPANTS.
Vakilzadeh N., Grouzmann E., Maillard M., Burnier M., Wuerzner G., 2015/06. pp. e125 dans Journal of Hypertension V. Peer-reviewed.
 
Early and irreversible recurrence MPO-ANCA-positive glomerulonephritis after renal transplantation
Le Berre L., Dufay A., Cantarovich D., Meurette A., Audrain M., Giral M., Blancho G., Fakhouri F., Hourmant M., Dantal J., 2015/06. Clin Nephrol, 83 (6) pp. 357-62.
 
Association of urinary calcium excretion with serum calcium and vitamin D levels.
Rathod A., Bonny O., Guessous I., Suter P.M., Conen D., Erne P., Binet I., Gabutti L., Gallino A., Muggli F. et al., 2015/03/06. Clinical journal of the American Society of Nephrology, 10 (3) pp. 452-462. Peer-reviewed.
Partagez:
Unicentre - CH-1015 Lausanne
Suisse
Tél. +41 21 692 11 11
Swiss University